Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessPharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies
The economic assessment of treatment options in a chronic and severe disease like Psoriatic Arthritis (PsA) is crucial to estimate the burden of costs. In particular, the impact of new costly medications such ...
-
Article
Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders